The phrase "application clinical trials" is not correct in English as it lacks clarity and proper structure.
It could be used in a context discussing the clinical trials related to a specific application, but it would need rephrasing for better understanding.
Example: "The application clinical trials for the new drug showed promising results."
Alternatives: "clinical trials for the application" or "application-based clinical trials".
This chapter summarizes the recent advancement of nanoparticles for tumor-targeted therapies, including theragnostic applications, clinical trials, and recent patents.
Her primary research interests are in translational research and early-application clinical trials with a focus on novel retinal imaging with spectral domain and swept source optical coherence tomography (SD and SSOCT).
This paper aims to provide a comprehensive review of mAbs development in China through systematic analysis of drug registry, patent applications, clinical trials, academic publication, and ongoing R&D projects.
This article addresses regulation of cell therapies in the European Union (EU), covering cell sourcing and applications for clinical trials and marketing authorisation applications.
However, high cytotoxicity and low transfection efficiency substantially restrict their application in clinical trials.
An approximate likelihood ratio test for a normal mean vector with nonnegative components with application to clinical trials.
The Preoperative Endocrine Prognostic Index (PEPI) that combines residual Ki67 score with measures of on-treatment ER and other clinicopathologic factors has also found application in clinical trials.
However it is uncertain whether the scale has sufficient sensitivity for application in clinical trials or whether the additional items are beneficial.
We review the futility clinical trial design (also known as the non-superiority design) with respect to its emergence and methodologic developments over the last decade, especially in regard to its application to clinical trials for neurological disorders.
This article reviews some ways in which the design and application of clinical trials could be improved so that the evidence produced would be more relevant to health-care providers and other decision makers.
